Park Medi World came to market through an IPO that opened on 10 December 2025 and closed on 12 December 2025, and the shares listed on 17 December 2025 on BSE, NSE. The price band was ₹154 to ₹162 per share and one lot was 92 shares, so the minimum application was ₹14,904. The issue size was ₹920 crore. It combined a fresh issue of new shares with an offer for sale by existing shareholders.
Kfin Technologies Ltd was the registrar to the issue, and Nuvama Wealth Management Ltd, CLSA India Pvt.Ltd, Dam Capital Advisors Ltd, Intensive Fiscal Services Pvt.Ltd were the lead managers.
As of 12 December 2025.
| Day |
|---|
| 1 |
| 2 |
| 3 |
Incorporated in 2011, Park Medi World Limited is a chain of private hospitals with the majority of its operations in North India, having a total bed capacity of 3,000 beds as of September 30, 2024. The firm has 13 multi-super speciality hospitals in its 'Park' brand. All the hospitals have NABH accreditation by the National Accreditation Board for Hospitals & Healthcare Providers, and seven are also NABL-accredited by the National Accreditation Board for Testing and Calibration Laboratories.
Facilities are present in Haryana, Delhi, Punjab, and Rajasthan. The Park Hospital provides over 30 super specialty and specialty services like internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics, and oncology. The hospitals have 805 intensive care unit (ICU) beds, 63 operating theatres (OTs), and an oxygen generation plant in each of them to cater to critical care.
As described in the offer document.
| Metric | 30-Sep-25 | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 |
|---|
Park Medi World mobilises Rs 276 crore via anchor book. The 1,70,37,036 equity shares, that had been allocated to the anchor investors, as mentioned earlier, comprised 95,67,908 shares, i.e., 56.16% of the total allotments to anchor investors being made to 4 domestic mutual funds, namely Kotak Mahindra AMC, Helios MF, ITI MF, and Taurus MF, while no application was received from life insurance companies and pension funds, the Park Hospital in its filing to exchanges said.
Other investors who participated in the anchor book included Allianz Global Investors Fund, Reliance General Insurance Company, Abakkus Asset Manager, Carnelian Bharat Amritkaal Fund, SBI General Insurance, Winro Commerical, Societe Generale, and Alchemie Ventures Fund.
Dr. Ajit Gupta, Dr. Ankit Gupta. Promoter holding 95.55% before the issue and 82.89% after.
Work out the listing gain for this IPO
If the retail portion is not fully subscribed, every valid application is allotted in full. If it is oversubscribed, SEBI's rules require that as many applicants as possible receive at least one lot, so the shares are allotted by a computerised lottery across all valid applications, one lot each, until the retail portion is exhausted. Applying for more lots does not improve your chance in a lottery; it only increases what you receive if the issue is under-subscribed.
The basis of allotment document, published by the registrar on the allotment date, states the ratio: for example, one applicant in seven received one lot.
Allotment status is published by the registrar on its website, searchable by PAN, application number or demat account, and also on the exchange's website. Allotted shares are credited to the demat account the day before listing, and blocked money for unsuccessful applications is released the same day. The Rupix app can check allotment status by PAN once the registrar publishes it.
Shares list within three working days of the issue closing. On listing day the exchanges run a special pre-open session from nine o'clock, during which orders are collected and an opening price is discovered from them; trading in the share begins after that, usually around ten. The opening price is the listing price that appears on this page once the issue has listed, and the listing gain or loss is the difference between it and the issue price.
For a mainboard issue, the share then trades in the normal way with the exchange's price band for a new listing. For an SME issue, shares trade in lots rather than one at a time, and the market can be thin, so selling on listing day is not always possible at the opening price. Capital gains on shares sold within a year of allotment are short-term and taxed at the short-term rate.
Park Medi World IPO was a ₹920 crore book-built issue, comprising a fresh issue of ₹770 crore and an offer for sale of ₹150 crore. It was priced at ₹154–₹162 per share with a lot size of 92 shares (₹14,904). The IPO was open from December 10 to December 12, 2025 and was subscribed 8.52x. Shares listed on BSE and NSE on December 17, 2025 at ₹158.80, a 2.0% discount to the issue price of ₹162. Kfin Technologies Ltd.
is the registrar. Nuvama Wealth Management Ltd. and 3 other book running lead managers manage the issue.
The price band of Park Medi World IPO is ₹154 to ₹162 per share.
The lot size of Park Medi World IPO is 92 shares.
The minimum investment for Park Medi World IPO is approximately ₹14,904 based on the upper price band.
The allotment date of Park Medi World IPO is Dec 15, 2025.
Park Medi World IPO's final recorded GMP before listing was ₹4 per share (a 2% premium over the ₹162 upper price band). The shares listed at ₹158.8. GMP is unofficial and does not forecast or guarantee the actual listing price.
Park Medi World IPO listed on Dec 17, 2025. It was issued at ₹158.8(NSE) and is currently around ₹224.45 as on 2-Nov-2026 3:30 PM, which is approximately 38.5% versus issue price. The 52-week high is ₹305.00.
You can check Park Medi World IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Park Medi World IPO allotment status on Rupix for quick and easy access.
₹154 to ₹162 per share, against a face value of ₹2. Most applicants bid at the cut-off price, the top of the band, so that the application was valid whatever price the issuer finally fixed.
One lot was 92 shares, and every application had to be a whole number of lots. At the top of the band that made the minimum application ₹14,904.
₹14,904, for one lot of 92 shares at the top of the price band. The amount was blocked in the applicant's bank account through ASBA or a UPI mandate while the issue was open, and released on the allotment date to applicants who were not allotted shares.
It opened on 10 December 2025 and closed on 12 December 2025.
The basis of allotment was published on 15 December 2025 by Kfin Technologies Ltd, and allotted shares were credited to demat accounts before listing.
The shares listed on 17 December 2025 on BSE, NSE.
The issue size was ₹920 crore. The fresh issue was 4,75,30,864 shares (aggregating up to ₹770 crore). The offer for sale was 92,59,259 shares (aggregating up to ₹150 crore).